Background
• Since 2010, the US CDC has recommended two drugs to treat N. gonorrhoeae
• At present, all recommended gonococcal treatment regimens contain Azithromycin 
Methods
• Neisseria Reference Laboratory -Test all urethral isolates using agar dilution -Screen others with Kirby-Bauer disk diffusion
• Small zones are further tested with agar dilution -Antimicrobial Susceptibility Panel includes:
-We used CDC "alert value" breakpoint ≥2 mcg/mL to denote AZM resistance.
• Penicillin (PCN)
Results: Jan 2014 -June 2015 
Conclusion
• Azithromycin resistance is increasing among MSM in Seattle • Efficacy of two-drug oral regimens is uncertain -Need for caution in using these regimens in MSM -Supports not routinely using expedited partner therapy in MSM
• Avoid 2g AZM alone
